Informa (LON:INF) Price Target Raised to GBX 1,040

Informa (LON:INF) had its price target upped by Berenberg Bank from GBX 965 to GBX 1,040 in a report issued on Friday,Digital Look reports. The brokerage presently has a “buy” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 15.45% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. cut their target price on shares of Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Citigroup reduced their price target on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a report on Thursday, April 9th. Five investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,095.

Informa Price Performance

Shares of INF opened at GBX 900.80 on Friday. The company has a debt-to-equity ratio of 61.56, a current ratio of 0.44 and a quick ratio of 1.70. The company’s fifty day moving average price is GBX 862.18 and its 200-day moving average price is GBX 832.65. The firm has a market capitalization of £11.29 billion, a PE ratio of 1,126.00, a price-to-earnings-growth ratio of 0.75 and a beta of 0.69. Informa has a 1-year low of GBX 719 and a 1-year high of GBX 1,000.

Informa (LON:INF) last announced its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a return on equity of 0.87% and a net margin of 1.64%. On average, equities research analysts predict that Informa will post 59.3240265 EPS for the current year.

Insider Buying and Selling at Informa

In related news, insider Gareth Wright acquired 222 shares of Informa stock in a transaction dated Wednesday, May 20th. The shares were acquired at an average cost of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Stephen A. Carter bought 222 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The stock was bought at an average price of GBX 809 per share, with a total value of £1,795.98. Insiders own 0.39% of the company’s stock.

Key Stories Impacting Informa

Here are the key news stories impacting Informa this week:

• Positive Sentiment: Full-year guidance raised: Informa said first-half growth strengthened and lifted its outlook for the year, suggesting resilient demand across its exhibitions, digital services and specialist information businesses. The improved forecast should support expectations for revenue and earnings growth. Informa lifts FY guidance as H1 growth strengthens
• Positive Sentiment: Technology-platform recognition: Informa TechTarget’s Portal platform won a 2026 CODiE Award, while BrightTALK received a leading global-event-platform ranking. The recognition reinforces the quality and competitive positioning of Informa’s technology offerings, although the direct near-term financial effect is likely limited. Informa TechTarget platform wins CODiE Award
• Positive Sentiment: Fashion-industry partnership: Informa’s SOURCING business and the Council of Fashion Designers of America launched a partnership focused on local manufacturing and supply-chain innovation. The initiative could strengthen Informa’s industry relationships and support future event and commercial opportunities. CFDA and SOURCING by Informa partnership
• Neutral Sentiment: Quarterly results: Informa reported earnings per share of 26.70 pence, with a 1.64% net margin and 0.87% return on equity. The figures provide support for the upgraded outlook, but the low profitability ratios remain a consideration for investors. Informa quarterly earnings report

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.